awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47161820-27C7D165-BFC2-4A94-A505-2BEE13AD705F
Q47161820-27C7D165-BFC2-4A94-A505-2BEE13AD705F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47161820-27C7D165-BFC2-4A94-A505-2BEE13AD705F
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.
P2860
Q47161820-27C7D165-BFC2-4A94-A505-2BEE13AD705F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47161820-27C7D165-BFC2-4A94-A505-2BEE13AD705F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e4ada489c955ff10bcfc223e33838c9f2183e09
P2860
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology.